, /PRNewswire/ — International Isotopes Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”) is pleased to announce that it has amended and finalized the Asset Purchase Agreement with AMICI, Inc., dated June 16th, 2023. To make up for a shortfall of inventory and assets INIS was to receive under the original agreement, INIS will receive the manufacturing molds, device registrations, trademarks, and all production rights to the AMICI, Inc. line of Xenon System products as well as the registered intellectual property to Swirler® and Tru-Fit™ Mouthpiece products.
Shahe Bagerdjian, President of INIS, commented, “We’re glad to have come to an agreement with Mr. Bono to finalize the Asset Purchase Agreement. It’s good to now have full control of the intellectual property behind the Swirler® and Tru-Fit™ and we look forward to the Xenon System joining the rest of our RadVent medical device lineup in 2025.”
AMICI, Inc. had been …